An Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body PET Scans in Patients for Whom 99m Tc MDP Bone Scans Would Normally be Indicated.
18F-Sodium Fluoride (Na18F) PET imaging is a nuclear medicine procedure, and its principal
radiopharmaceutical, Na18F, has been used for scanning the skeleton for the spread of cancer
for more that 30 years, but has not been approved by Health Canada because less expensive
alternate drugs have been available (99mTc diphosphonates). Given the sudden and drastic
change in the availability of 99mTc, an acceptable alternative for 99mTc-diphosphonates is
needed as soon as possible.
Observational Model: Cohort, Time Perspective: Prospective
Establish the feasibility of using locally produced 18F-Sodium Fluoride for PET bone scans as a substitute for 99mTc MPD
Canada: Health Canada